NCT00080899 2015-03-06Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate CancerNational Cancer Institute (NCI)Phase 2 Completed23 enrolled 3 charts
NCT00288067 2014-10-06Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1/2 Terminated32 enrolled 7 charts